• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗血小板生成素抗体对 2 型糖尿病患者血小板计数影响的初步研究。

A Pilot Study on the Effect of Anti-Thrombopoietin Antibody on Platelet Count in Patients with Type 2 Diabetes.

机构信息

Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto 602-8566, Japan.

Department of Endocrinology and Diabetology, Ayabe City Hospital, Ayabe 623-0011, Japan.

出版信息

Molecules. 2020 Apr 4;25(7):1667. doi: 10.3390/molecules25071667.

DOI:10.3390/molecules25071667
PMID:32260359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7181124/
Abstract

Thrombopoietin (THPO) is a circulatory cytokine that plays an important role in platelet production. The presence of anti-THPO antibody relates to thrombocytopenia and is rarely seen in hematopoietic and autoimmune diseases. To date, there had been no reports that focused on the anti-THPO antibody in patients with type 2 diabetes mellitus (T2DM). To evaluate prevalence of the anti-THPO antibody in patients with T2DM and the relationship between anti-THPO antibody and platelet count, a cross-sectional study was performed on 82 patients with T2DM. The anti-THPO antibody was measured by ELISA using preserved sera and detected in 13 patients. The average platelet count was significantly lower in patients with the anti-THPO antibody than in those without the anti-THPO antibody. Multivariate linear regression analyses showed a significant relationship between the anti-THPO antibody and platelet count, after adjusting for other variables. To our best knowledge, this was the first report on the effect of the anti-THPO antibody on platelet count in patients with T2DM. Further investigation is needed to validate the prevalence and pathological significance of the anti-THPO antibody in patients with T2DM.

摘要

血小板生成素(THPO)是一种循环细胞因子,在血小板生成中起重要作用。抗 THPO 抗体的存在与血小板减少症有关,在造血和自身免疫性疾病中很少见。迄今为止,尚无关于 2 型糖尿病(T2DM)患者抗 THPO 抗体的报道。为了评估 T2DM 患者抗 THPO 抗体的患病率以及抗 THPO 抗体与血小板计数之间的关系,对 82 例 T2DM 患者进行了横断面研究。使用保存的血清通过 ELISA 测量抗 THPO 抗体,并在 13 例患者中检测到。与无抗 THPO 抗体的患者相比,抗 THPO 抗体患者的平均血小板计数明显较低。多元线性回归分析表明,在调整其他变量后,抗 THPO 抗体与血小板计数之间存在显著关系。据我们所知,这是第一项关于抗 THPO 抗体对 T2DM 患者血小板计数影响的报告。需要进一步研究来验证 T2DM 患者抗 THPO 抗体的患病率和病理意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48d1/7181124/b2d27fc99174/molecules-25-01667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48d1/7181124/301411931346/molecules-25-01667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48d1/7181124/b2d27fc99174/molecules-25-01667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48d1/7181124/301411931346/molecules-25-01667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48d1/7181124/b2d27fc99174/molecules-25-01667-g002.jpg

相似文献

1
A Pilot Study on the Effect of Anti-Thrombopoietin Antibody on Platelet Count in Patients with Type 2 Diabetes.抗血小板生成素抗体对 2 型糖尿病患者血小板计数影响的初步研究。
Molecules. 2020 Apr 4;25(7):1667. doi: 10.3390/molecules25071667.
2
Thrombopoietin Contributes to Enhanced Platelet Activation in Patients with Type 1 Diabetes Mellitus.血小板生成素有助于 1 型糖尿病患者血小板的激活增强。
Int J Mol Sci. 2021 Jun 29;22(13):7032. doi: 10.3390/ijms22137032.
3
Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice.肝生成素基因沉默可降低血小板计数并抑制转染 MMTV-PyMT 小鼠的乳腺癌进展。
Blood Adv. 2019 Oct 22;3(20):3080-3091. doi: 10.1182/bloodadvances.2019000250.
4
TGFβ-Mediated Downregulation of Thrombopoietin Is Associated With Platelet Decline in Asymptomatic SIV Infection.TGFβ 介导体外血小板生成素下调与无症状 SIV 感染中的血小板减少有关。
J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):510-6. doi: 10.1097/QAI.0000000000000048.
5
[Efficacy of thrombopoietin in bone marrow failure].[血小板生成素在骨髓衰竭中的疗效]
Rinsho Ketsueki. 2020;61(10):1449-1458. doi: 10.11406/rinketsu.61.1449.
6
Thrombopoietin participates in platelet activation in COVID-19 patients.血小板生成素参与 COVID-19 患者的血小板活化。
EBioMedicine. 2022 Nov;85:104305. doi: 10.1016/j.ebiom.2022.104305. Epub 2022 Oct 13.
7
Suspects in the tale of lupus-associated thrombocytopenia.狼疮相关血小板减少症事件中的可疑因素。
Clin Exp Immunol. 2006 Jul;145(1):71-80. doi: 10.1111/j.1365-2249.2006.03122.x.
8
Thrombopoietin Metabolically Primes Hematopoietic Stem Cells to Megakaryocyte-Lineage Differentiation.促血小板生成素代谢启动造血干细胞向巨核细胞谱系分化。
Cell Rep. 2018 Nov 13;25(7):1772-1785.e6. doi: 10.1016/j.celrep.2018.10.059.
9
Serum thrombopoietin levels and anti-thrombopoietin antibodies in systemic lupus erythematosus.系统性红斑狼疮患者的血清血小板生成素水平及抗血小板生成素抗体
Lupus. 2002;11(4):221-6. doi: 10.1191/0961203302lu177oa.
10
Multifaceted roles of thrombopoietin in hematopoietic stem cell regulation.血小板生成素在造血干细胞调控中的多方面作用。
Ann N Y Acad Sci. 2020 Apr;1466(1):51-58. doi: 10.1111/nyas.14169. Epub 2019 Jul 10.

引用本文的文献

1
Refractory Immune Thrombocytopenic Purpura With Low Immature Platelet Fraction.难治性免疫性血小板减少症伴低未成熟血小板分数
Cureus. 2025 Apr 18;17(4):e82533. doi: 10.7759/cureus.82533. eCollection 2025 Apr.
2
Investigating the Role of Anti-TPO Antibodies in HIV-Associated Thrombocytopenia before and after Initiation of HAART: A Case-Control Longitudinal Study.抗甲状腺过氧化物酶抗体在 HAART 前后对 HIV 相关血小板减少症作用的研究:一项病例对照纵向研究。
Viruses. 2023 Nov 8;15(11):2226. doi: 10.3390/v15112226.

本文引用的文献

1
NAFLD/NASH in patients with type 2 diabetes and related treatment options.非酒精性脂肪性肝病/非酒精性脂肪性肝炎患者的 2 型糖尿病及其相关治疗选择。
J Endocrinol Invest. 2018 May;41(5):509-521. doi: 10.1007/s40618-017-0799-3. Epub 2017 Nov 30.
2
Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population.使用FibroScan® XL探头的受控衰减参数对亚洲人群非酒精性脂肪性肝病的肝脂肪变性进行定量分析。
United European Gastroenterol J. 2017 Feb;5(1):76-85. doi: 10.1177/2050640616646528. Epub 2016 Jun 23.
3
Cellular misfolded proteins rescued from degradation by MHC class II molecules are possible targets for autoimmune diseases.
从降解中被II类主要组织相容性复合体分子拯救的细胞错误折叠蛋白可能是自身免疫性疾病的靶点。
J Biochem. 2015 Nov;158(5):367-72. doi: 10.1093/jb/mvv093. Epub 2015 Sep 17.
4
A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP.利妥昔单抗联合重组人血小板生成素对比利妥昔单抗治疗糖皮质激素抵抗或复发的免疫性血小板减少症的多中心随机开放标签研究
Blood. 2015 Mar 5;125(10):1541-7. doi: 10.1182/blood-2014-06-581868. Epub 2015 Jan 9.
5
Clinical marker of platelet hyperreactivity in diabetes mellitus.糖尿病患者血小板高反应性的临床标志物。
Diabetes Metab J. 2013 Dec;37(6):423-8. doi: 10.4093/dmj.2013.37.6.423.
6
Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation.不同阶段非酒精性脂肪性肝病患者的肝硬度测量:诊断性能和临床病理相关性。
Dig Dis Sci. 2013 Jan;58(1):265-74. doi: 10.1007/s10620-012-2306-1. Epub 2012 Jul 12.
7
Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.使用受控衰减参数(CAP)和瞬时弹性成像技术进行非侵入性诊断肝脂肪变性。
Liver Int. 2012 Jul;32(6):911-8. doi: 10.1111/j.1478-3231.2012.02820.x.
8
EASL clinical practical guidelines: management of alcoholic liver disease.欧洲肝脏研究学会临床实践指南:酒精性肝病的管理
J Hepatol. 2012 Aug;57(2):399-420. doi: 10.1016/j.jhep.2012.04.004. Epub 2012 May 26.
9
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population.验证 FIB4 指数在日本非酒精性脂肪性肝病人群中的应用。
BMC Gastroenterol. 2012 Jan 5;12:2. doi: 10.1186/1471-230X-12-2.
10
Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietin.重组人红细胞生成素治疗后产生的抗红细胞生成素和抗血小板生成素抗体。
Int Immunopharmacol. 2011 Dec;11(12):2237-41. doi: 10.1016/j.intimp.2011.10.014. Epub 2011 Oct 31.